Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as an Add-on to Metformin, Thiazolidinediones, or Both, in Patients With Type 2 Diabetes (SUSTAIN 2): A 56-Week, Double-Blind, Phase 3a, Randomised Trial
Weight loss varies from person to person, but clinical studies suggest that individuals may lose between 5% to 10% of their body weight in the first 1216 weeks when combined with lifestyle changes
Not only am I changing the weight of the patient sitting in front of me, but more importantly, Im changing their overall health, Horn said
GLP-1 receptor agonists promote weight loss through reduced appetite, increased feelings of fullness, and delayed gastric emptying
JACC Heart Fail 2015;3:275-82
These medications are increasingly recognized for their role in lowering the risk of adverse outcomes, making them a valuable option in managing cardiovascular health